Developing novel targeted and immune therapy approaches for acute myeloid leukemia (AML). The goal of the research in Dr. Eckfeldt's lab is to investigate the genetics and signaling pathways that drive acute myeloid leukemia (AML) to provide a foundation for the development of novel targeted and immune treatment approaches for AML. His research is focused on identifying the critical pathways that drive AML growth and survival, evaluating the effects of targeted therapies in preclinical cancer models, and studying how targeted therapies influence the susceptibility of cancer cells to immune therapies such as Natural Killer (NK) cell immunotherapy, an area of institutional expertise.
M Health Fairview Masonic Cancer Clinic: 909 Fulton St SE, Minneapolis, MN 55455, USA
Get the latest thought leadership on Acute Myeloid Leukemia delivered straight to your inbox.
Subscribe to the weekly "HealthTree Community for Acute Myeloid Leukemia Newsletter" for Acute Myeloid Leukemia news, life
Acute Myeloid Leukemia stories, Acute Myeloid Leukemia clinical trials, Acute Myeloid Leukemia 101 articles and events with Acute Myeloid Leukemia
Thanks to our HealthTree Community for Acute Myeloid Leukemia Sponsors:
HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.